{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T06:15:43Z","timestamp":1787724943996,"version":"build-2784847793"},"publisher-location":"Berlin\/Heidelberg","reference-count":107,"publisher":"Springer-Verlag","isbn-type":[{"value":"3540297839","type":"print"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1007\/3-540-29784-7_11","type":"book-chapter","created":{"date-parts":[[2006,8,2]],"date-time":"2006-08-02T18:34:39Z","timestamp":1154543679000},"page":"215-232","source":"Crossref","is-referenced-by-count":43,"title":["The Dopamine Transporter: A Vigilant Border Control for Psychostimulant Action"],"prefix":"10.1007","author":[{"given":"J. M.","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"11_CR1","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1002\/syn.890140409","volume":"14","author":"M.E. Alburges","year":"1993","unstructured":"Alburges ME, Narang N, Wamsley JK (1993) Alterations in the dopaminergic receptor system after chronic administration of cocaine. Synapse 14:314\u2013323","journal-title":"Synapse"},{"key":"11_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1146\/annurev.ne.16.030193.000445","volume":"16","author":"S.G. Amara","year":"1993","unstructured":"Amara SG, Kuhar MJ (1993) Neurotransmitter transporters: recent progress. Annu Rev Neurosci 16:73\u201393","journal-title":"Annu Rev Neurosci"},{"key":"11_CR3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1054-3589(08)60718-8","volume":"42","author":"S.G. Amara","year":"1998","unstructured":"Amara SG, Sonders MS, Zahniser NR, Povlock SL, Daniels GM (1998) Molecular physiology and regulation of catecholamine transporters. Adv Pharmacol 42:164\u2013168","journal-title":"Adv Pharmacol"},{"key":"11_CR4","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0091-3057(92)90095-W","volume":"41","author":"Z. Amit","year":"1992","unstructured":"Amit Z, Smith BR (1992) Remoxipride, a specific D2 dopamine antagonist: an examination of its self-administration liability and its effects on d-amphetamine self-administration. Pharmacol Biochem Behav 41:259\u2013261","journal-title":"Pharmacol Biochem Behav"},{"key":"11_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(74)90888-9","volume":"82","author":"I.M. Asher","year":"1974","unstructured":"Asher IM, Aghajanian GK (1974) 6-Hydroxydopamine lesions of olfactory tubercles and caudate nuclei: effect on amphetamine-induced stereotyped behavior in rats. Brain Res 82:1\u201312","journal-title":"Brain Res"},{"key":"11_CR6","doi-asserted-by":"crossref","first-page":"10304","DOI":"10.1523\/JNEUROSCI.18-24-10304.1998","volume":"18","author":"M. Batchelor","year":"1998","unstructured":"Batchelor M, Schenk JO (1998) Protein kinase A activity may kinetically upregulate the striatal transporter for dopamine. J Neurosci 18:10304\u201310309","journal-title":"J Neurosci"},{"key":"11_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s002329900388","volume":"164","author":"M.L. Beckman","year":"1998","unstructured":"Beckman ML, Quick MW (1998) Neurotransmitter transporters: regulators of function and functional regulation. J Membr Biol 164:1\u201310","journal-title":"J Membr Biol"},{"key":"11_CR8","doi-asserted-by":"crossref","first-page":"9134","DOI":"10.1523\/JNEUROSCI.21-23-09134.2001","volume":"21","author":"M. Benoit-Marand","year":"2001","unstructured":"Benoit-Marand M, Borrelli E, Gonon F (2001) Inhibition of dopamine release via presynaptic D2 receptors: time course and functional characteristics in vivo. JNeurosci 21:9134\u20139141","journal-title":"JNeurosci"},{"key":"11_CR9","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/S0959-4388(00)00088-X","volume":"10","author":"R.D. Blakely","year":"2000","unstructured":"Blakely RD, Bauman AL (2000) Biogenic amine transporters: regulation in flux. Curr Opin Neurobiol 10:328\u2013336","journal-title":"Curr Opin Neurobiol"},{"key":"11_CR10","first-page":"413","volume":"174","author":"G.R. Breese","year":"1970","unstructured":"Breese GR, Traylor TD (1970) Effect of 6-hydroxydopamine on brain norepinephrine and dopamine: Evidence for selective degeneration of catecholamine neurons. J Pharmacol Exp Ther 174:413\u2013420","journal-title":"J Pharmacol Exp Ther"},{"key":"11_CR11","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/BF02246095","volume":"122","author":"W.A. Carlezon Jr","year":"1995","unstructured":"Carlezon WA Jr, Devine DP, Wise RA (1995) Habit-forming actions of nomifensine in nucleus accumbens. Psychopharmacology (Berl) 122:194\u2013197","journal-title":"Psychopharmacology"},{"key":"11_CR12","doi-asserted-by":"publisher","first-page":"16046","DOI":"10.1073\/pnas.0403299101","volume":"101","author":"L. Carvelli","year":"2004","unstructured":"Carvelli L, McDonald PW, Blakely RD, Defelice LJ (2004) Dopamine transporters depolarize neurons by a channel mechanism. Proc Natl Acad Sci U S A 101:16046\u201316051","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR13","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0304-3940(94)90096-5","volume":"176","author":"W.A. Cass","year":"1994","unstructured":"Cass WA, Gerhardt GA (1994) Direct in vivo evidence that D2 dopamine receptors can modulate dopamine uptake. Neurosci Lett 176:259\u2013263","journal-title":"Neurosci Lett"},{"key":"11_CR14","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1124\/jpet.103.055095","volume":"307","author":"L. Chi","year":"2003","unstructured":"Chi L, Reith ME (2003) Substrate-induced trafficking of the dopamine transporter in heterologously expressing cells and in rat striatal synaptosomal preparations. J Pharmacol Exp Ther 307:729\u2013736","journal-title":"J Pharmacol Exp Ther"},{"key":"11_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/BF02244434","volume":"105","author":"D. Clark","year":"1991","unstructured":"Clark D, Furmidge LJ, Petry N, Tong ZY, Ericsson M, Johnson D (1991) Behavioural profile of partial D2 dopamine receptor agonists. 1. Atypical inhibitionofd-amphetamine-induced locomotor hyperactivity and stereotypy. Psychopharmacology (Berl) 105:381\u2013392","journal-title":"Psychopharmacology"},{"key":"11_CR16","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/BF00422974","volume":"39","author":"I. Creese","year":"1974","unstructured":"Creese I, Iversen SD (1974) The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat. Psychopharmacologia 39:345\u2013357","journal-title":"Psychopharmacologia"},{"key":"11_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/S0740-5472(01)00192-1","volume":"21","author":"C.A. Dackis","year":"2001","unstructured":"Dackis CA, O\u2019Brien CP (2001) Cocaine dependence: a disease of the brain\u2019s reward centers. J Subst Abuse Treat 21:111\u2013117","journal-title":"J Subst Abuse Treat"},{"key":"11_CR18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.2042-7158.1973.tb10616.x","volume":"25","author":"W.M. Davis","year":"1973","unstructured":"Davis WM, Smith SG (1973) Blocking effect of alpha-methyltyrosine on amphetamine based reinforcement. J Pharm Pharmacol 25:174\u2013177","journal-title":"J Pharm Pharmacol"},{"key":"11_CR19","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1006\/bbrc.2002.6384","volume":"290","author":"L.C. Daws","year":"2002","unstructured":"Daws LC, Callaghan PD, Moron JA, Kahlig KM, Shippenberg TS, Javitch JA, Galli A (2002) Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochem Biophys Res Commun 290:1545\u20131550","journal-title":"Biochem Biophys Res Commun"},{"key":"11_CR20","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/0091-3057(82)90138-1","volume":"17","author":"R. Garza de la","year":"1982","unstructured":"de la Garza R, Johanson CE (1982) Effects of haloperidol and physostigmine on self-administration of local anesthetics. Pharmacol Biochem Behav 17:1295\u20131299","journal-title":"Pharmacol Biochem Behav"},{"key":"11_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/S1054-3589(08)60724-3","volume":"42","author":"L.J. DeFelice","year":"1998","unstructured":"DeFelice LJ, Galli A (1998) Electrophysiological analysis of transporter function. Adv Pharmacol 42:186\u2013190","journal-title":"Adv Pharmacol"},{"key":"11_CR22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1749-6632.1988.tb42095.x","volume":"537","author":"A.Y. Deutch","year":"1988","unstructured":"Deutch AY, Goldstein M, Baldino F Jr, Roth RH (1988) Telencephalic projections of the A8 dopamine cell group. Ann N Y Acad Sci 537:27\u201350","journal-title":"Ann N Y Acad Sci"},{"key":"11_CR23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1046\/j.1471-4159.1999.0720148.x","volume":"72","author":"S.D. Dickinson","year":"1999","unstructured":"Dickinson SD, Sabeti J, Larson GA, Giardina K, Rubinstein M, Kelly MA, Grandy DK, Low MJ, Gerhardt GA, Zahniser NR (1999) Dopamine D2 receptor-deficient mice exhibit decreased dopamine transporter function but no changes in dopamine release in dorsal striatum. J Neurochem 72:148\u2013156","journal-title":"J Neurochem"},{"key":"11_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0006-8993(73)90493-9","volume":"55","author":"H.C. Fibiger","year":"1973","unstructured":"Fibiger HC, Zis AP, McGeer EG (1973) Feeding and drinking deficits after 6-hydroxydopamine administration in the rat: similarities to the lateral hypothalamic syndrome. Brain Res 55:135\u2013148","journal-title":"Brain Res"},{"key":"11_CR25","first-page":"203","volume":"208","author":"J. Fischer","year":"1979","unstructured":"Fischer J, Cho A (1979) Chemical release of dopamine from striatal homogenates: evidence for an exchange diffusion model. J Pharmacol Exp Ther 208:203\u2013209","journal-title":"J Pharmacol Exp Ther"},{"key":"11_CR26","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S0022-3565(24)36858-2","volume":"282","author":"A.E. Fleckenstein","year":"1997","unstructured":"Fleckenstein AE, Metzger RR, Wilkins DG, Gibb JW, Hanson GR (1997) Rapid and reversible effects of methamphetamine on dopamine transporters. J Pharmacol Exp Ther 282:834\u2013838","journal-title":"J Pharmacol Exp Ther"},{"key":"11_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0014-2999(99)00588-9","volume":"382","author":"A.E. Fleckenstein","year":"1999","unstructured":"Fleckenstein AE, Haughey HM, Metzger RR, Kokoshka JM, Riddle EL, Hanson JE, Gibb JW, Hanson GR (1999) Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function. Eur J Pharmacol 382:45\u201349","journal-title":"Eur J Pharmacol"},{"key":"11_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/0014-2999(91)90294-Z","volume":"202","author":"L.J. Furmidge","year":"1991","unstructured":"Furmidge LJ, Exner M, Clark D (1991) Role of dopamine D1 and D2 receptors in mediating the d-amphetamine discriminative cue. Eur J Pharmacol 202:191\u2013199","journal-title":"Eur J Pharmacol"},{"key":"11_CR29","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S0165-6147(02)02044-8","volume":"23","author":"R.R. Gainetdinov","year":"2002","unstructured":"Gainetdinov RR, Sotnikova TD, Caron MG (2002) Monoamine transporter pharmacology and mutant mice. Trends Pharmacol Sci 23:367\u2013373","journal-title":"Trends Pharmacol Sci"},{"key":"11_CR30","doi-asserted-by":"publisher","first-page":"13260","DOI":"10.1073\/pnas.95.22.13260","volume":"95","author":"A. Galli","year":"1998","unstructured":"Galli A, Blakely RD, DeFelice LJ (1998) Patch-clamp and amperometric recordings from norepinephrine transporters: channel activity and voltage-dependent uptake. Proc Natl Acad Sci U S A 95:13260\u201313265","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR31","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/0165-6147(93)90029-J","volume":"14","author":"B. Giros","year":"1993","unstructured":"Giros B, Caron MG (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14:43\u201349","journal-title":"Trends Pharmacol Sci"},{"key":"11_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/0014-5793(91)81406-X","volume":"295","author":"B. Giros","year":"1991","unstructured":"Giros B, el Mestikawy S, Bertrand L, Caron MG (1991) Cloning and functional characterization of a cocaine-sensitive dopamine transporter. FEBS Lett 295:149\u2013154","journal-title":"FEBS Lett"},{"key":"11_CR33","first-page":"383","volume":"42","author":"B. Giros","year":"1992","unstructured":"Giros B, el Mestikawy S, Godinot N, Zheng K, Han H, Yang-Feng T, Caron MG (1992) Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. Mol Pharmacol 42:383\u2013390","journal-title":"Mol Pharmacol"},{"key":"11_CR34","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/379606a0","volume":"379","author":"B. Giros","year":"1996","unstructured":"Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606\u2013612","journal-title":"Nature"},{"key":"11_CR35","first-page":"30","volume":"153","author":"J. Glowinski","year":"1966","unstructured":"Glowinski J, Axelrod J, Iversen LL (1966) Regional studies of catecholamines in the rat brain. IV. Effects of drugs on the disposition and metabolism of H3-norepinephrine and H3-dopamine. J Pharmacol Exp Ther 153:30\u201341","journal-title":"J Pharmacol Exp Ther"},{"key":"11_CR36","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1124\/mol.66.1.137","volume":"66","author":"M.E. Gnegy","year":"2004","unstructured":"Gnegy ME, Khoshbouei H, Berg KA, Javitch JA, Clarke WP, Zhang M, Galli A (2004) Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter. Mol Pharmacol 66:137\u2013143","journal-title":"Mol Pharmacol"},{"key":"11_CR37","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1016\/S0021-9258(17)37256-3","volume":"269","author":"H. Gu","year":"1994","unstructured":"Gu H, Wall SC, Rudnick G (1994) Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. J Biol Chem 269:7124\u20137130","journal-title":"J Biol Chem"},{"key":"11_CR38","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ejphar.2003.08.064","volume":"479","author":"J.M. Gulley","year":"2003","unstructured":"Gulley JM, Zahniser NR (2003) Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands. Eur J Pharmacol 479:139\u2013152","journal-title":"Eur J Pharmacol"},{"key":"11_CR39","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1046\/j.1471-4159.2002.01133.x","volume":"83","author":"J.M. Gulley","year":"2002","unstructured":"Gulley JM, Doolen S, Zahniser NR (2002) Brief, repeated exposure to substrates down-regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo. J Neurochem 83:400\u2013411","journal-title":"J Neurochem"},{"key":"11_CR40","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/0006-2952(75)90152-5","volume":"24","author":"R. Heikkila","year":"1975","unstructured":"Heikkila R, Orlansky H, Cohen G (1975) Studies on the distinction between uptake inhibition and release of [3H]dopamine in rat brain tissue slices. Biochem Pharmacol 24:847\u2013852","journal-title":"Biochem Pharmacol"},{"key":"11_CR41","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/192172a0","volume":"192","author":"G. Hertting","year":"1961","unstructured":"Hertting G, Axelrod J (1961) Fate of tritiated noradrenaline at the sympathetic nerve endings. Nature 192:172\u2013173","journal-title":"Nature"},{"key":"11_CR42","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/nn920","volume":"5","author":"S.L. Ingram","year":"2002","unstructured":"Ingram SL, Prasad BM, Amara SG (2002) Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons. Nat Neurosci 5:971\u2013978","journal-title":"Nat Neurosci"},{"key":"11_CR43","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/211969a0","volume":"211","author":"O. Jardetzky","year":"1966","unstructured":"Jardetzky O (1966) Simple allosteric model for membrane pumps. Nature 211:969\u2013970","journal-title":"Nature"},{"key":"11_CR44","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0026-895X(24)13059-3","volume":"54","author":"L.D. Jayanthi","year":"1998","unstructured":"Jayanthi LD, Apparsundaram S, Malone MD, Ward E, Miller DM, Eppler M, Blakely RD (1998) The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant-and cocaine-sensitive dopamine transporter. Mol Pharmacol 54:601\u2013609","journal-title":"Mol Pharmacol"},{"key":"11_CR45","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1046\/j.1471-4159.1999.0732406.x","volume":"73","author":"S.R. Jones","year":"1999","unstructured":"Jones SR, Joseph JD, Barak LS, Caron MG, Wightman RM (1999) Dopamine neuronal transport kinetics and effects of amphetamine. J Neurochem 73:2406\u20132414","journal-title":"J Neurochem"},{"key":"11_CR46","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejphar.2003.08.065","volume":"479","author":"K.M. Kahlig","year":"2003","unstructured":"Kahlig KM, Galli A (2003) Regulation of dopamine transporter function and plasma membrane expressionby dopamine, amphetamine, and cocaine. Eur J Pharmacol 479:153\u2013158","journal-title":"Eur J Pharmacol"},{"key":"11_CR47","doi-asserted-by":"publisher","first-page":"8966","DOI":"10.1074\/jbc.M303976200","volume":"279","author":"K.M. Kahlig","year":"2004","unstructured":"Kahlig KM, Javitch JA, Galli A (2004) Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier. J Biol Chem 279:8966\u20138975","journal-title":"J Biol Chem"},{"key":"11_CR48","doi-asserted-by":"publisher","first-page":"3495","DOI":"10.1073\/pnas.0407737102","volume":"102","author":"K.M. Kahlig","year":"2005","unstructured":"Kahlig KM, Binda F, Khoshbouei H, Blakely RD, McMahon DG, Javitch JA, Galli A (2005) Amphetamine induces dopamine efflux through a dopamine transporter channel. Proc Natl Acad Sci U S A 102:3495\u20133500","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR49","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0022-3565(24)29628-2","volume":"297","author":"L. Kantor","year":"2001","unstructured":"Kantor L, Hewlett GH, Park YH, Richardson-Burns SM, Mellon MJ, Gnegy ME (2001) Protein kinase C and intracellular calcium are required for amphetamine-mediated dopamine release via the norepinephrine transporter in undifferentiated PC12 cells. J Pharmacol Exp Ther 297:1016\u20131024","journal-title":"J Pharmacol Exp Ther"},{"key":"11_CR50","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/0006-8993(75)90233-4","volume":"94","author":"P. Kelly","year":"1975","unstructured":"Kelly P, Seviour P, Iversen S (1975) Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94:507\u2013522","journal-title":"Brain Res"},{"key":"11_CR51","doi-asserted-by":"publisher","first-page":"12070","DOI":"10.1074\/jbc.M212815200","volume":"278","author":"H. Khoshbouei","year":"2003","unstructured":"Khoshbouei H, Wang H, Lechleiter JD, Javitch JA, Galli A (2003) Amphetamine-induced dopamine efflux. A voltage-sensitive and intracellular Na+-dependentmechanism. J Biol Chem 278:12070\u201312077","journal-title":"J Biol Chem"},{"key":"11_CR52","doi-asserted-by":"publisher","first-page":"E78","DOI":"10.1371\/journal.pbio.0020078","volume":"2","author":"H. Khoshbouei","year":"2004","unstructured":"Khoshbouei H, Sen N, Guptaroy B, Johnson L, Lund D, Gnegy ME, Galli A, Javitch JA (2004) N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biol 2:E78","journal-title":"PLoS Biol"},{"key":"11_CR53","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1126\/science.1948035","volume":"254","author":"J.E. Kilty","year":"1991","unstructured":"Kilty JE, Lorang D, Amara SG (1991) Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 254:578\u2013579","journal-title":"Science"},{"key":"11_CR54","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0022-3565(24)39277-8","volume":"293","author":"S. Kim","year":"2000","unstructured":"Kim S, Westphalen R, Callahan B, Hatzidimitriou G, Yuan J, Ricaurte GA (2000) Toward development of an in vitro model of methamphetamine-induced dopamine nerve terminal toxicity. J Pharmacol Exp Ther 293:625\u2013633","journal-title":"J Pharmacol Exp Ther"},{"key":"11_CR55","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0022-3565(24)29360-5","volume":"298","author":"H.L. Kimmel","year":"2001","unstructured":"Kimmel HL, Joyce AR, Carroll FI, Kuhar MJ (2001) Dopamine D1 and D2 receptors influence dopamine transporter synthesis and degradation in the rat. J Pharmacol Exp Ther 298:129\u2013140","journal-title":"J Pharmacol Exp Ther"},{"key":"11_CR56","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0014-2999(98)00741-9","volume":"361","author":"J.M. Kokoshka","year":"1998","unstructured":"Kokoshka JM, Vaughan RA, Hanson GR, Fleckenstein AE (1998) Nature of methampheta-mine-induced rapid and reversible changes in dopamine transporters. Eur J Pharmacol 361:269\u2013275","journal-title":"Eur J Pharmacol"},{"key":"11_CR57","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0165-6147(92)90060-J","volume":"13","author":"G.F. Koob","year":"1992","unstructured":"Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. Trends Pharmacol Sci 13:177\u2013184","journal-title":"Trends Pharmacol Sci"},{"key":"11_CR58","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1126\/science.2903550","volume":"242","author":"G.F. Koob","year":"1988","unstructured":"Koob GF, Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science 242:715\u2013723","journal-title":"Science"},{"key":"11_CR59","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1471-4159.1990.tb08847.x","volume":"55","author":"B.K. Krueger","year":"1990","unstructured":"Krueger BK (1990) Kinetics and block of dopamine uptake in synaptosomes from rat caudate nucleus. J Neurochem 55:260\u2013267","journal-title":"J Neurochem"},{"key":"11_CR60","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/0166-2236(91)90141-G","volume":"14","author":"M.J. Kuhar","year":"1991","unstructured":"Kuhar MJ, Ritz MC, Boja JW (1991) The dopamine hypothesis of the reinforcing properties of cocaine. Trends Neurosci 14:299\u2013302","journal-title":"Trends Neurosci"},{"key":"11_CR61","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0165-6147(96)01034-6","volume":"18","author":"S.Z. Langer","year":"1997","unstructured":"Langer SZ (1997) 25 years since the discovery of presynaptic receptors: present knowledge and future perspectives. Trends Pharmacol Sci 18:95\u201399","journal-title":"Trends Pharmacol Sci"},{"key":"11_CR62","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1152\/physrev.1991.71.1.155","volume":"71","author":"M. Moal Le","year":"1991","unstructured":"Le Moal M, Simon H (1991) Mesocorticolimbic dopaminergic network: functional and regulatory roles. Physiol Rev 71:155\u2013234","journal-title":"Physiol Rev"},{"key":"11_CR63","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev.pa.34.040194.001251","volume":"34","author":"H.A. Lester","year":"1994","unstructured":"Lester HA, Mager S, Quick MW, Corey JL (1994) Permeation properties of neurotransmitter transporters. Annu Rev Pharmacol Toxicol 34:219\u2013249","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"11_CR64","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S0896-6273(00)80213-5","volume":"17","author":"H.A. Lester","year":"1996","unstructured":"Lester HA, Cao Y, Mager S (1996) Listening to neurotransmitter transporters. Neuron 17:807\u2013810","journal-title":"Neuron"},{"key":"11_CR65","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/0006-8993(93)90932-D","volume":"628","author":"K.Y. Little","year":"1993","unstructured":"Little KY, Kirkman JA, Carroll FI, Clark TB, Duncan GE (1993) Cocaine use increases [3H]WIN35428 binding sites in human striatum. Brain Res 628:17\u201325","journal-title":"Brain Res"},{"key":"11_CR66","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1124\/mol.61.2.436","volume":"61","author":"K.Y. Little","year":"2002","unstructured":"Little KY, Elmer LW, Zhong H, Scheys JO, Zhang L (2002) Cocaine induction of dopamine transporter trafficking to the plasma membrane. Mol Pharmacol 61:436\u2013445","journal-title":"Mol Pharmacol"},{"key":"11_CR67","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/j.1749-6632.1999.tb09330.x","volume":"877","author":"D.S. Lorrain","year":"1999","unstructured":"Lorrain DS, Arnold GM, Vezina P (1999) Mesoaccumbens dopamine and the self-administration of amphetamine. Ann N Y Acad Sci 877:820\u2013822","journal-title":"Ann N Y Acad Sci"},{"key":"11_CR68","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/0091-3057(85)90071-1","volume":"23","author":"M.R. Lynch","year":"1985","unstructured":"Lynch MR, Wise RA (1985) Relative effectiveness of pimozide, haloperidol and trifluoperazine on self-stimulationrate-intensity functions. Pharmacol Biochem Behav 23:777\u2013780","journal-title":"Pharmacol Biochem Behav"},{"key":"11_CR69","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/0091-3057(79)90040-6","volume":"11","author":"W.H. Lyness","year":"1979","unstructured":"Lyness WH, Friedle NM, Moore KE (1979) Destruction of dopaminergic nerve terminals in nucleus accumbens: effect on d-amphetamine self-administration. Pharmacol Biochem Behav 11:553\u2013556","journal-title":"Pharmacol Biochem Behav"},{"key":"11_CR70","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1046\/j.1471-4159.2002.00820.x","volume":"81","author":"D.C. Mash","year":"2002","unstructured":"Mash DC, Pablo J, Ouyang Q, Hearn WL, Izenwasser S (2002) Dopamine transport function is elevated in cocaine users. J Neurochem 81:292\u2013300","journal-title":"J Neurochem"},{"key":"11_CR71","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1124\/mol.59.1.113","volume":"59","author":"R.D. Mayfield","year":"2001","unstructured":"Mayfield RD, Zahniser NR (2001) Dopamine D2 receptor regulation of the dopamine transporter expressed in Xenopus laevis oocytes is voltage-independent. Mol Pharmacol 59:113\u2013121","journal-title":"Mol Pharmacol"},{"key":"11_CR72","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1111\/j.1471-4159.1993.tb02185.x","volume":"61","author":"S.M. Meiergerd","year":"1993","unstructured":"Meiergerd SM, Patterson TA, Schenk JO (1993) D2 receptors may modulate the function of the striatal transporter for dopamine: kinetic evidence from studies in vitro and in vivo. J Neurochem 61:764\u2013767","journal-title":"J Neurochem"},{"key":"11_CR73","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.pharmthera.2004.07.006","volume":"104","author":"H.E. Melikian","year":"2004","unstructured":"Melikian HE (2004) Neurotransmitter transporter trafficking: endocytosis, recycling, and regulation. Pharmacol Ther 104:17\u201327","journal-title":"Pharmacol Ther"},{"key":"11_CR74","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0014-2999(98)00196-4","volume":"349","author":"R.R. Metzger","year":"1998","unstructured":"Metzger RR, Hanson GR, Gibb JW, Fleckenstein AE (1998) 3-4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function. Eur J Pharmacol 349:205\u2013210","journal-title":"Eur J Pharmacol"},{"key":"11_CR75","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.ejphar.2003.08.066","volume":"479","author":"O.V. Mortensen","year":"2003","unstructured":"Mortensen OV, Amara SG (2003) Dynamic regulation of the dopamine transporter. Eur J Pharmacol 479:159\u2013170","journal-title":"Eur J Pharmacol"},{"key":"11_CR76","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0165-0173(87)90011-7","volume":"434","author":"R.D. Oades","year":"1987","unstructured":"Oades RD, Halliday GM (1987) Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity. Brain Res 434:117\u2013165","journal-title":"Brain Res"},{"key":"11_CR77","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/j.1471-4159.1993.tb05864.x","volume":"60","author":"L.H. Parsons","year":"1993","unstructured":"Parsons LH, Schad CA, Justice JB Jr (1993) Co-administration of the D2 antagonist pimozide inhibits up-regulation of dopamine release and uptake induced by repeated cocaine. J Neurochem 60:376\u2013379","journal-title":"J Neurochem"},{"key":"11_CR78","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/BF00427441","volume":"84","author":"H.O. Pettit","year":"1984","unstructured":"Pettit HO, Ettenberg A, Bloom FE, Koob GF (1984) Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats. Psychopharmacology (Berl) 84:167\u2013173","journal-title":"Psychopharmacology"},{"key":"11_CR79","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1523\/JNEUROSCI.17-09-03254.1997","volume":"17","author":"R.C. Pierce","year":"1997","unstructured":"Pierce RC, Kalivas PW (1997) Repeated cocaine modifies the mechanism by which amphetamine releases dopamine. J Neurosci 17:3254\u20133261","journal-title":"J Neurosci"},{"key":"11_CR80","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1124\/mol.59.1.83","volume":"59","author":"P. Porzgen","year":"2001","unstructured":"Porzgen P, Park SK, Hirsh J, Sonders MS, Amara SG (2001) The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines. Mol Pharmacol 59:83\u201395","journal-title":"Mol Pharmacol"},{"key":"11_CR81","doi-asserted-by":"crossref","first-page":"7561","DOI":"10.1523\/JNEUROSCI.21-19-07561.2001","volume":"21","author":"B.M. Prasad","year":"2001","unstructured":"Prasad BM, Amara SG (2001) The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage. J Neurosci 21:7561\u20137567","journal-title":"J Neurosci"},{"key":"11_CR82","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1074\/jbc.273.4.2458","volume":"273","author":"S. Ramamoorthy","year":"1998","unstructured":"Ramamoorthy S, Giovanetti E, Qian Y, Blakely RD (1998) Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J Biol Chem 273:2458\u20132466","journal-title":"J Biol Chem"},{"key":"11_CR83","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1126\/science.2820058","volume":"237","author":"M.C. Ritz","year":"1987","unstructured":"Ritz MC, Lamb RJ, Goldberg SR, Kuhar MJ (1987) Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 237:1219\u20131223","journal-title":"Science"},{"key":"11_CR84","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/0091-3057(77)90084-3","volume":"6","author":"D.C. Roberts","year":"1977","unstructured":"Roberts DC, Corcoran ME, Fibiger HC (1977) On the role of ascending catecholaminergic systems in intravenous self-administration of cocaine. Pharmacol Biochem Behav 6:615\u2013620","journal-title":"Pharmacol Biochem Behav"},{"key":"11_CR85","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1523\/JNEUROSCI.21-04-01413.2001","volume":"21","author":"V. Sandoval","year":"2001","unstructured":"Sandoval V, Riddle EL, Ugarte YV, Hanson GR, Fleckenstein AE (2001) Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model. J Neurosci 21:1413\u20131419","journal-title":"J Neurosci"},{"key":"11_CR86","doi-asserted-by":"publisher","first-page":"6850","DOI":"10.1073\/pnas.110035297","volume":"97","author":"C. Saunders","year":"2000","unstructured":"Saunders C, Ferrer JV, Shi L, Chen J, Merrill G, Lamb ME, Leeb-Lundberg LM, Carvelli L, Javitch JA, Galli A (2000) Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. Proc Natl Acad Sci U S A 97:6850\u20136855","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR87","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1046\/j.1471-4159.2003.02050.x","volume":"87","author":"Y. Schmitz","year":"2003","unstructured":"Schmitz Y, Benoit-Marand M, Gonon F, Sulzer D (2003) Presynaptic regulation of dopaminergic neurotransmission. J Neurochem 87:273\u2013289","journal-title":"J Neurochem"},{"key":"11_CR88","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1124\/mol.67.1.140","volume":"67","author":"S. Seidel","year":"2005","unstructured":"Seidel S, Singer EA, Just H, Farhan H, Scholze P, Kudlacek O, Holy M, Koppatz K, Krivanek P, Freissmuth M, Sitte HH (2005) Amphetamines take two to tango: an oligomer-based counter-transport model of neurotransmitter transport explores the amphetamine action. Mol Pharmacol 67:140\u2013151","journal-title":"Mol Pharmacol"},{"key":"11_CR89","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1126\/science.1948034","volume":"254","author":"S. Shimada","year":"1991","unstructured":"Shimada S, Kitayama S, Lin CL, Patel A, Nanthakumar E, Gregor P, Kuhar M, Uhl G (1991) Cloning and expression of a cocaine-sensitive dopamine transporter complementary DNA. Science 254:576\u2013578","journal-title":"Science"},{"key":"11_CR90","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1046\/j.1471-4159.1998.71031289.x","volume":"71","author":"H.H. Sitte","year":"1998","unstructured":"Sitte HH, Huck S, Reither H, Boehm S, Singer EA, Pifl C (1998) Carrier-mediated release, transport rates, and charge transfer induced by amphetamine, tyramine, and dopamine in mammalian cells transfected with the human dopamine transporter. J Neurochem 71:1289\u20131297","journal-title":"J Neurochem"},{"key":"11_CR91","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0959-4388(96)80111-5","volume":"6","author":"M.S. Sonders","year":"1996","unstructured":"Sonders MS, Amara SG (1996) Channels in transporters. Curr Opin Neurobiol 6:294\u2013302","journal-title":"Curr Opin Neurobiol"},{"key":"11_CR92","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1523\/JNEUROSCI.17-03-00960.1997","volume":"17","author":"M.S. Sonders","year":"1997","unstructured":"Sonders MS, Zhu SJ, Zahniser NR, Kavanaugh MP, Amara SG (1997) Multiple ionic conductances of the human dopamine transporter: the actions of dopamine and psychostimulants. J Neurosci 17:960\u2013974","journal-title":"J Neurosci"},{"key":"11_CR93","first-page":"1678","volume":"271","author":"J.K. Staley","year":"1994","unstructured":"Staley JK, Hearn WL, Ruttenber AJ, Wetli CV, Mash DC (1994) High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J Pharmacol Exp Ther 271:1678\u20131685","journal-title":"J Pharmacol Exp Ther"},{"key":"11_CR94","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0166-2236(03)00063-8","volume":"26","author":"D. Sulzer","year":"2003","unstructured":"Sulzer D, Galli A (2003) Dopamine transport currents are promoted from curiosity to physiology. Trends Neurosci 26:173\u2013176","journal-title":"Trends Neurosci"},{"key":"11_CR95","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/0896-6273(90)90339-H","volume":"5","author":"D. Sulzer","year":"1990","unstructured":"Sulzer D, Rayport S (1990) Amphetamine and other psychostimulants reduce pH gradients in midbrain dopaminergic neurons and chromaffin granules: a mechanism of action. Neuron 5:797\u2013808","journal-title":"Neuron"},{"key":"11_CR96","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1749-6632.1992.tb26020.x","volume":"654","author":"D. Sulzer","year":"1992","unstructured":"Sulzer D, Pothos E, Sung HM, Maidment NT, Hoebel BG, Rayport S (1992) Weak base model of amphetamine action. Ann N Y Acad Sci 654:525\u2013528","journal-title":"Ann N Y Acad Sci"},{"key":"11_CR97","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1523\/JNEUROSCI.15-05-04102.1995","volume":"15","author":"D. Sulzer","year":"1995","unstructured":"Sulzer D, Chen TK, Lau YY, Kristensen H, Rayport S, Ewing A (1995) Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport. J Neurosci 15:4102\u20134108","journal-title":"J Neurosci"},{"key":"11_CR98","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","volume":"75","author":"D. Sulzer","year":"2005","unstructured":"Sulzer D, Sonders MS, Poulsen NW, Galli A (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog Neurobiol 75:406\u2013433","journal-title":"Prog Neurobiol"},{"key":"11_CR99","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/S0361-9230(01)00472-5","volume":"54","author":"T.L. Thompson","year":"2001","unstructured":"Thompson TL, Bridges SR, Weirs WJ (2001) Alteration of dopamine transport in the striatum and nucleus accumbens of ovariectomized and estrogen-primed rats following N-(p-isothiocyanatophenethyl) spiperone (NIPS) treatment. Brain Res Bull 54:631\u2013638","journal-title":"Brain Res Bull"},{"key":"11_CR100","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/nrn1008","volume":"4","author":"G.E. Torres","year":"2003","unstructured":"Torres GE, Gainetdinov RR, Caron MG (2003) Plasma membrane monoamine transporters: structure, regulation and function. Nat Rev Neurosci 4:13\u201325","journal-title":"Nat Rev Neurosci"},{"key":"11_CR101","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.mp.4001964","volume":"7","author":"G.R. Uhl","year":"2002","unstructured":"Uhl GR, Hall FS, Sora I (2002) Cocaine, reward, movement and monoamine transporters. Mol Psychiatry 7:21\u201326","journal-title":"Mol Psychiatry"},{"key":"11_CR102","doi-asserted-by":"publisher","first-page":"11168","DOI":"10.1073\/pnas.88.24.11168","volume":"88","author":"T.B. Usdin","year":"1991","unstructured":"Usdin TB, Mezey E, Chen C, Brownstein MJ, Hoffman BJ (1991) Cloning of the cocaine-sensitive bovine dopamine transporter. Proc Natl Acad Sci U S A 88:11168\u201311171","journal-title":"Proc Natl Acad Sci U S A"},{"key":"11_CR103","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1523\/JNEUROSCI.14-05-02966.1994","volume":"14","author":"J.M. Wilson","year":"1994","unstructured":"Wilson JM, Nobrega JN, Carroll ME, Niznik HB, Shannak K, Lac ST, Pristupa ZB, Dixon LM, Kish SJ (1994) Heterogeneous subregional binding patterns of 3H-WIN35428 and 3H-GBR12935 are differentially regulated by chronic cocaine self-administration. J Neurosci 14:2966\u20132979","journal-title":"J Neurosci"},{"key":"11_CR104","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/S0896-6273(02)00965-0","volume":"36","author":"R.A. Wise","year":"2002","unstructured":"Wise RA (2002) Brain reward circuitry: insights from unsensed incentives. Neuron 36:229\u2013240","journal-title":"Neuron"},{"key":"11_CR105","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0378-1119(99)00143-2","volume":"233","author":"X. Wu","year":"1999","unstructured":"Wu X, Gu HH (1999) Molecular cloning of the mouse dopamine transporter and pharmacological comparison with the human homologue. Gene 233:163\u2013170","journal-title":"Gene"},{"key":"11_CR106","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1126\/science.1114313","volume":"187","author":"R.A. Yokel","year":"1975","unstructured":"Yokel RA, Wise RA (1975) Increased lever pressing for amphetamine after pimozide in rats: implications for a dopamine theory of reward. Science 187:547\u2013549","journal-title":"Science"},{"key":"11_CR107","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0163-7258(01)00158-9","volume":"92","author":"N.R. Zahniser","year":"2001","unstructured":"Zahniser NR, Doolen S (2001) Chronic and acute regulation of Na+\/Cl\u2212-dependent neurotransmitter transporters: drugs, substrates, presynaptic receptors, and signaling systems. Pharmacol Ther 92:21\u201355","journal-title":"Pharmacol Ther"}],"container-title":["Handbook of Experimental Pharmacology","Neurotransmitter Transporters"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/3-540-29784-7_11.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T09:02:05Z","timestamp":1736499725000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/3-540-29784-7_11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[null]]},"ISBN":["3540297839"],"references-count":107,"URL":"https:\/\/doi.org\/10.1007\/3-540-29784-7_11","relation":{},"subject":[]}}